TYPES OF PAPERS Mutation Research Reviews publishes Full-length reviews comprehensively covering and critically
analysing a topic and invited papers in the series Reflections in Mutation Research, in which research and techniques that have
played an important part in the development of the field of mutation research are revisited and their significance discussed.
On-line
Submission.Authors are encouraged to submit their manuscript on-line. Via the Elsevier Editorial System page of this journal (http://ees.elsevier.com/mutrev)
where you will be guided stepwise through the creation and uploading of the various files. The Editors welcome submissions by the authors
of the names and addresses of five individuals who could expertly review the paper.
Conflict of Interest: The Journal requires
full disclosure of all potential conflicts of interest. At the end of the manuscript text (and in the cover letter of the manuscript),
under a subheading "Conflict of Interest statement", all authors must disclose any financial and personal relationships with other people
or organisations that could inappropriately influence (bias) their work. If there are no conflicts of interest, the authors should state,
"The authors declare that there are no conflicts of interest." Signed copies of the Mutation Research- Reviews Conflict of Interest
policy form are required upon submission. The Conflict of Interest policy form can be downloaded here.
In order to minimize delays, we strongly advise that the signed copies of these statements are prepared before you submit your manuscript.
The corresponding author is responsible for sharing this document with all co-authors. Each and every co-author must sign an individual
disclosure form. The corresponding author is responsible for uploading their form and those of their co-authors.
General arrangement
of papers. Papers should be in English, typewritten, and double-spaced. They should include key words (3-6 words or short
phrases) and an abstract of up to 300 words. The Introduction should summarize the research problem and the pertinent findings.
The text may be divided into sections such as Materials and methods, Results, Discussion, etc. All main sections should be numbered.
In papers mentioning chemicals, authors are requested to include CAS registry numbers.
Preparation of text. Each manuscript
should have a separate title page which includes only the title, authors' full names and complete addresses of academic of professional
affiliations; the author to whom proofs and correspondence should be addressed should be indicated by an asterisk and a telephone/fax
number and e-mail address included.
Colour illustrations. Please make sure that
artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. Polaroid prints are not suitable.
If, together with your accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge that these
figures will appear in colour on the Web (e.g. Science Direct and other sites) regardless of whether or not these illustrations are reproduced
in colour in the printed version. For colour reproduction in print, you will receive information regarding the costs from Elsevier after
receipt of your accepted article. Please indicate your preference for colour in print or on the Web only. Reproduction of colour in review
articles, if considered functional by the editors, will be free of charge to the authors.
Tables should be typed with double
line spacing and should have a heading.
References. Only papers using the numbered reference system will be accepted, i.e.
references are numbered by order of citation in the text. Journal titles should be abbreviated to conform with Chemical Abstracts Bibliographic
Guide for Authors and Editors 1974.
Examples:
[1] B.N. Ames, J. McCann, E. Yamasaki, Methods for detecting carcinogens and mutagens
with the Salmonella/mammalian-microsome mutagenicity test, Mutation Res. 31 (1975) 347-363.
[2] L. Ehrenberg, C.A. Wachtmeister,
Safety precautions in work with mutagenic and carcinogenic chemicals, in: B.J. Kilbey, M.S. Legator, W. Nichols and C. Ramel (Eds.),
Handbook of Mutagenicity Test Procedures, Elsevier, Amsterdam, 1977, pp. 401-410.
Nomenclature. Authors are requested to adopt
the nomenclature system for human gene mutations recommended by the HUGO MDI Nomenclature Working Group. Guidelines for this system can
be found at http://journals.wiley.com/1059-7794/nomenclature.html. USEBACK BUTTON TO RETURN TO THIS
PAGE, NOT "Return to Instructions to Authors"
Language and language services. Only papers written in English are considered.
Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/locate/languagepolishing
or contact authorsupport@elsevier.com for more information. Please note Elsevier neither endorses nor takes responsibility for any products,
goods or services offered by outside vendors through our services or in any advertising. For more information please refer to our Terms
and Conditions http://www.elsevier.com/termsandconditions
Submission of a manuscript will be held to imply that
it contains original work and that it has not been published or submitted for publication elsewhere. It also implies the transfer of
the Copyright from the author to the publisher.
Proofs One set of page proofs in PDF format will be sent by e-mail to
the corresponding Author, to be checked for typesetting/editing. No changes in, or additions to, the accepted (and subsequently edited)
manuscript will be allowed at this stage. Proofreading is solely your responsibility. A form with queries from the copyeditor may accompany
your proofs. Please answer all queries and make any corrections or additions required. The Publisher reserves the right to proceed with
publication if corrections are not communicated. Return corrections within 2 days of receipt of the proofs. Should there be no corrections,
please confirm this. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as
possible. In order to do this we need your help. When you receive the (PDF) proof of your article for correction, it is important to
ensure that all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please
ensure your first sending is complete. Note that this does not mean you have any less time to make your corrections, just that only one
set of corrections will be accepted.
Offprints. 25 offprints of each article are sent to the author(s) free of charge. Additional
offprints can be ordered by the author(s). Offprint requests after publication will be subject to an extra charge.
Information
For enquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage
at http://www.elsevier.com/journals. From here you can also track accepted articles (http://www.elsevier.com/trackarticle)
and set up e-mail alerts to inform you of when an article's status has changed, as well as detailed artwork guidelines, copyright information,
frequently asked questions and more.
US National Institutes of Health (NIH) voluntary posting "Public Access Policy"
Elsevier facilitates author posting in connection with the voluntary posting request of the NIH (referred to as the NIH "Public Access
Policy", see http://publicaccess.nih.gov/) by submitting the peer-reviewed author's manuscript directly to PubMed Central
on request from the author, immediately after final publication. Please
e-mail us at NIHauthorrequest@elsevier.com that
your work has received NIH funding (with the NIH grant/project number(s), as well as name and e-mail address of the Principal Investigator(s))
and that you intend to respond to the NIH request. Upon such confirmation, Elsevier will submit to PubMed Central on your behalf a version
of your manuscript that will include peer-review comments, for public access posting 12 months after the final publication date. This
will ensure that you will have responded fully to the NIH request policy. There will be no need for you to post your manuscript directly
to PubMed Central, and any such posting is prohibited (although Elsevier will not request that manuscripts authored and posted by US
government employees should be taken down from PubMed Central). Individual modifications to this general policy may apply to some Elsevier
journals and its society publishing partners.
